THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS APPROVED THEM FOR PREVENTING HEART ...
Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...
An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the ...
Jefferies analyst Roger Song maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) yesterday and set a price target of ...
AMA President Dr Danielle McMullen provides an update on the past week at Federal AMA. What a whirlwind week it's been!
A once-weekly injectable form of the drug is sold as Wegovy and has also ... 46 weeks of treatment with their dual glucagon/GLP1 agonist survodutide (BI 456906) given as a weekly subcutaneous ...
A new study reports that GLP-1 medications may provide benefits to cognitive and behavioral health, including lowered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback